|
Volumn 96, Issue 12, 1999, Pages 6925-6930
|
Multiple event activation of a generic prodrug trigger by antibody catalysis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CAMPTOTHECIN;
CATALYTIC ANTIBODY;
DOXORUBICIN;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY 38C2;
PRODRUG;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CANCER CELL DESTRUCTION;
CATALYSIS;
CONTROLLED STUDY;
DRUG ACTIVATION;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG TARGETING;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
ANIMALS;
ANTIBODIES;
ANTINEOPLASTIC AGENTS;
CAMPTOTHECIN;
DOXORUBICIN;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
HUMANS;
MICE;
PRODRUGS;
TUMOR CELLS, CULTURED;
|
EID: 0033536048
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.96.12.6925 Document Type: Article |
Times cited : (107)
|
References (16)
|